6645 |
北城證券研發部提供 非經同意不得轉載 本刊內容僅供參考 投資人應謹慎考量投資風險 本公司不負任何法律責任 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6645 金萬林-創 |
實收資本額 |
609 (百萬) |
|
|
|
|
|
|
|
|
|
市 場
別 |
TSE |
上 市 日 期 |
2023/12/21 |
|
|
|
|
|
|
|
|
|
發 言
人 |
楊文明 |
電 話 |
(02)26976888 |
|
|
|
|
|
|
|
|
|
地 址 |
新北市汐止區新台五路一段97號30樓 |
|
|
|
|
|
|
|
|
|
產 業
別 |
傳產-生技 |
|
|
|
|
|
|
|
|
|
主要產品 |
生物醫學產品銷售暨基因檢測分析服務 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/5/2 股價 |
22.25 |
法人買賣超合計(近一日) |
賣超 -1 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌 |
1.10
|
法人買賣超合計(近一週) |
買超
3.16 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌幅 |
5.20
|
法人買賣超合計(近一月) |
賣超 -4.28 張 |
|
|
|
|
|
|
|
|
|
券 資 比 |
0.00
|
外資連3賣 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
最新股利發放 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
殖利率 |
|
|
|
|
|
|
|
2024/05/21 |
0.10 |
1.41 |
2023/06/20 |
2023/06/20 |
0.45% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
股利年度 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
扣抵率(%) |
殖利率 |
股利殖利率 |
現金殖利率 |
|
|
|
|
2024 |
2025/05/27 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2023 |
2024/05/21 |
0.00 |
0.50 |
2024/07/16 |
|
|
2.25% |
0.02% |
0% |
|
|
|
|
2022 |
2023/05/18 |
0.10 |
1.41 |
2023/06/20 |
2023/06/20 |
|
6.81% |
0.06% |
0.45% |
|
|
|
|
2021 |
2022/06/14 |
0.25 |
3.00 |
2022/07/26 |
2022/07/26 |
|
14.61% |
0.13% |
1.12% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
機構估稅後EPS |
-2.96 |
K(9) |
73.34 |
|
技術面 |
技術面 |
基本面 |
基本面 |
籌碼面 |
|
|
|
|
淨值(元) |
10.45 |
D(9) |
67.54 |
評分表 |
(短線) |
(中長線) |
(安全性) |
(成長性) |
|
|
|
|
預估本益比 |
-7.52 |
周K(9) |
55.82 |
|
0.8 |
0.8 |
0.8 |
0.8 |
1 |
|
|
|
|
股價淨值比 |
2.13 |
周D(9) |
37.28 |
綜合評分: |
4.2 |
建議: |
觀望 |
目標價: |
21.61 |
|
|
|
|
月線乖離率 |
10.52 |
季線乖離率 |
0.82 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/4/2 |
2025/4/11 |
2025/4/18 |
2025/4/25 |
2025/5/2 |
20*PE |
|
3*PB |
33.38 |
|
|
|
|
股價 |
21.00 |
18.75 |
20.75 |
21.75 |
22.25 |
15*PE |
|
2*PB |
22.25 |
|
|
|
|
成交量(千股) |
108 |
612 |
274 |
202 |
279 |
10*PE |
|
1*PB |
11.13 |
|
|
|
|
資餘 |
44 |
55 |
83 |
84 |
85 |
5*PE |
|
0.5*PB |
5.56 |
|
|
|
|
券餘 |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
季IFRS財報(損益單季) |
202501 |
202404 |
202403 |
202402 |
202401 |
202304 |
202303 |
202302 |
|
|
|
|
營業收入淨額(千) |
|
159,334
|
124,538
|
121,220
|
96,435
|
130,628
|
100,910
|
88,305
|
|
|
|
|
營業成本(千) |
|
141,570
|
104,768
|
110,603
|
88,357
|
114,151
|
81,068
|
77,964
|
|
|
|
|
營業毛利(千) |
|
17,764
|
19,770
|
10,617
|
8,078
|
16,477
|
19,842
|
10,341
|
|
|
|
|
營業費用(千) |
|
59,742
|
52,365
|
54,580
|
54,330
|
63,735
|
50,554
|
48,749
|
|
|
|
|
營業利益(千) |
|
-41,978 |
-32,595 |
-43,963 |
-46,252 |
-47,258 |
-30,712 |
-38,408 |
|
|
|
|
營業外收入及支出(千) |
|
-2,162 |
-1,187 |
-770 |
-593 |
921
|
-597 |
89 |
|
|
|
|
稅前純益(千) |
|
-44,140 |
-33,782 |
-44,733 |
-46,845 |
-46,337 |
-31,309 |
-38,319 |
|
|
|
|
所得稅(千) |
|
422
|
1,875
|
-4,212 |
-7,707 |
-8,328 |
-4,961 |
-8,028 |
|
|
|
|
稅後純益(千) |
|
-44,562 |
-35,657 |
-40,521 |
-39,138 |
-38,009 |
-26,348 |
-30,291 |
|
|
|
|
其他綜合損益(千) |
|
240
|
-149 |
70 |
247
|
-357 |
109
|
111
|
|
|
|
|
綜合損益(千) |
|
-44,322 |
-35,806 |
-40,451 |
-38,891 |
-38,366 |
-26,239 |
-30,180 |
|
|
|
|
原始每股稅前盈餘(元) |
|
-0.73 |
-0.63 |
-0.89 |
-0.93 |
-0.95 |
-0.68 |
-0.83 |
|
|
|
|
原始每股稅後盈餘(元) |
|
-0.73 |
-0.66 |
-0.81 |
-0.78 |
-0.78 |
-0.57 |
-0.66 |
|
|
|
|
毛利率(%) |
|
11.15
|
15.87
|
8.76
|
8.38
|
12.61
|
19.66
|
11.71
|
|
|
|
|
營業利益率(%) |
|
-26.35 |
-26.17 |
-36.27 |
-47.96 |
-36.18 |
-30.44 |
-43.49 |
|
|
|
|
稅後純益率(%) |
|
-27.97 |
-28.63 |
-33.43 |
-40.58 |
-29.10 |
-26.11 |
-34.30 |
|
|
|
|
稅後權益報酬率(%) |
|
-7.74 |
-6.85 |
-7.41 |
-6.84 |
-6.95 |
-4.98 |
-5.42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
月營收 |
單月營收(千) |
累計營收(千) |
單月MoM |
單月YoY |
累計YoY |
累計稅前EPS |
備註 |
近3月營收(千) |
近3月年成長 |
|
|
|
|
202504 |
0 |
0 |
0.00
|
0.00
|
0.00
|
|
|
0 |
0 |
|
|
|
|
202503 |
37,091 |
102,338 |
15.85
|
1.96
|
6.12
|
|
|
102,338
|
6.12 |
|
|
|
|
202502 |
32,017 |
65,247 |
-3.65 |
6.10
|
8.65
|
|
|
125,912
|
12.59 |
|
|
|
|
202501 |
33,230 |
33,230 |
-45.22 |
11.22
|
11.22
|
|
|
145,041
|
10.54 |
|
|
|
|
202412 |
60,665 |
501,527 |
18.61
|
17.17
|
20.85
|
-2.78 |
創近一年新高 |
159,333
|
26.71 |
|
|
|
|
202411 |
51,146 |
440,860 |
7.63
|
3.21
|
21.37
|
|
|
145,127
|
32.66 |
|
|
|
|
202410 |
47,522 |
389,714 |
2.29
|
94.61
|
24.24
|
|
|
135,970
|
34.19 |
|
|
|
|
202409 |
46,459 |
342,193 |
10.65
|
31.16
|
20.33
|
-2.06 |
|
124,539
|
17.75 |
|
|
|
|
202408 |
41,989 |
295,733 |
16.34
|
1.21
|
16.67
|
|
|
127,536
|
23.55 |
|
|
|
|
202407 |
36,091 |
253,744 |
-27.02 |
25.06
|
19.49
|
|
|
125,654
|
32.9 |
|
|
|
|
202406 |
49,456 |
217,655 |
23.31
|
50.40
|
18.62
|
-1.50 |
|
121,220
|
36 |
|
|
|
|
202405 |
40,107 |
168,197 |
26.69
|
22.26
|
11.68
|
|
|
108,143
|
16.92 |
|
|
|
|
202404 |
31,657 |
128,090 |
-12.98 |
35.02
|
8.73
|
|
|
98,212
|
9.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
|
|
|
|
5850 |
統一 |
10 |
10 |
0 |
9200 |
凱基 |
-11 |
0 |
11 |
|
|
|
|
9300 |
華南永昌 |
8 |
8 |
0 |
9800 |
元大 |
-8 |
0 |
8 |
|
|
|
|
6450 |
永全 |
2 |
2 |
0 |
9100 |
群益金鼎 |
-2 |
0 |
2 |
|
|
|
|
7000 |
兆豐 |
1 |
4 |
3 |
8150 |
台新 |
-1 |
0 |
1 |
|
|
|
|
8840 |
玉山 |
1 |
1 |
0 |
8440 |
摩根大通 |
-1 |
0 |
1 |
|
|
|
|
8840 |
玉山 |
1 |
1 |
0 |
8450 |
康和 |
0 |
0 |
0 |
|
|
|
|
8880 |
國泰 |
0 |
0 |
0 |
7790 |
國票 |
0 |
0 |
0 |
|
|
|
|
9600 |
富邦 |
0 |
0 |
0 |
8880 |
國泰 |
0 |
0 |
0 |
|
|
|
|
8880 |
國泰 |
0 |
0 |
0 |
7790 |
國票 |
0 |
0 |
0 |
|
|
|
|
9600 |
富邦 |
0 |
0 |
0 |
6460 |
大昌 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20200624 |
金萬林新冠檢測試劑獲外銷查驗登記 最快7月可外銷 |
|
|
|
|
20200602 |
金萬林前4月稅後虧損1890萬元 每股虧0.92元 |
|
|
|
|
20200325 |
金萬林攜美廠開發新冠病毒檢測 首批量產6000套 |
|
|
|
|
20250307 |
浩宇生醫上櫃股價飆三成 兩檔跟著漲停 |
|
|
|
|
20240607 |
振曜股東會/通過配發4元現金股利 新任董事長由宗緒福擔任 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股TOP15買賣超券商籌碼統計(20日) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1日籌碼集中度 |
0 |
|
10日籌碼集中度 |
5.7 |
|
單日買賣超 |
0 |
|
|
|
5日籌碼集中度 |
4.8 |
|
20日籌碼集中度 |
5.6 |
優 |
累計買賣超 |
15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股借券統計(20日) |
千張大戶統計(20週) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
單日借賣張數 |
83 |
借券餘額 |
138 |
千張大戶戶數 |
7 |
大戶比例 |
26.55 |
|
|
|
|
|
|
|
|
|
|
|
|
更新日期: |
2025/5/2 15:51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|